Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft...

Area of Science:

• Biomedical Engineering
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Bacterial adherence to medical devices causes significant infections, particularly in vascular surgery.
• Staphylococci are common pathogens responsible for biomaterial infections, leading to severe complications.
• Vascular prosthetic graft infections pose a major threat, often resulting in high morbidity and mortality.

Purpose of the Study:

• To evaluate the topical prophylactic efficacy of temporin A and RNAIII-inhibiting protein (RIP) against Staphylococcus aureus and Staphylococcus epidermidis.
• To assess the effectiveness of these agents, alone and in combination, in preventing vascular prosthetic graft infections in a rat model.

Main Methods:

• A rat model was utilized, implanting Dacron prostheses and inoculating with Staphylococcus strains.
• Groups received no prophylaxis, or grafts treated with temporin A, RIP, rifampin, or combinations thereof.
• Infection levels were quantified using agar cultures.

Main Results:

• Temporin A and RIP demonstrated superior efficacy compared to rifampin when used alone.
• All tested combinations significantly enhanced antimicrobial effects over single agents.
• The combination of temporin A and RIP achieved 100% elimination of staphylococcal infection.

Conclusions:

• Temporin A and RIP show significant potential as topical antimicrobial chemoprophylactic agents.
• Combination therapy with temporin A and RIP offers a highly effective strategy for preventing vascular graft infections.
• These findings support the development of novel prophylactic treatments for surgical site infections.